"In-depth" 510(k) reviews will be completed within 90 days, CDRH's Burlington says.
This article was originally published in The Gray Sheet
"IN-DEPTH REVIEW" ON ALL 510(K) SUBMISSIONS WITHIN 90 DAYS will be pursued by FDA's Center for Devices and Radiological Health for fiscal year 1996 (begun Oct. 1), CDRH Director Bruce Burlington says in a letter highlighting improvements in the center's device review program. "Our goal is to screen for completeness and perform at least one cycle of in-depth review on all submissions within a 90-day review cycle," Burlington says, at which time sponsors can expect to receive a determination of substantially equivalent, not substantially equivalent, or a request for additional data.
You may also be interested in...
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.